Mikhail Ruda

5.1k total citations
13 papers, 1.1k citations indexed

About

Mikhail Ruda is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mikhail Ruda has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 3 papers in Internal Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mikhail Ruda's work include Acute Myocardial Infarction Research (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Mikhail Ruda is often cited by papers focused on Acute Myocardial Infarction Research (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Mikhail Ruda collaborates with scholars based in United States, Russia and United Kingdom. Mikhail Ruda's co-authors include Keith A.A. Fox, José López‐Sendón, Andrzej Budaj, David A. Morrow, Sabina A. Murphy, Elliott M. Antman, Carolyn H. McCabe, Sema Güneri, Eugene Braunwald and Harvey D. White and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Mikhail Ruda

13 papers receiving 1.1k citations

Peers

Mikhail Ruda
E.M. Pelletier United States
Henrik Renlund Sweden
Petr Widimský Czechia
HD White New Zealand
Axel de Labriolle United States
Kelly Maresh United States
Khagendra Dahal United States
Jindřich Špinar Czechia
Conor F. Lundergan United States
Alec Vahanian France
E.M. Pelletier United States
Mikhail Ruda
Citations per year, relative to Mikhail Ruda Mikhail Ruda (= 1×) peers E.M. Pelletier

Countries citing papers authored by Mikhail Ruda

Since Specialization
Citations

This map shows the geographic impact of Mikhail Ruda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Ruda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Ruda more than expected).

Fields of papers citing papers by Mikhail Ruda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Ruda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Ruda. The network helps show where Mikhail Ruda may publish in the future.

Co-authorship network of co-authors of Mikhail Ruda

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Ruda. A scholar is included among the top collaborators of Mikhail Ruda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Ruda. Mikhail Ruda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bonaca, Marc P., Shinya Goto, Deepak L. Bhatt, et al.. (2016). Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction. Circulation. 134(12). 861–871. 31 indexed citations
2.
Bonaca, Marc P., Robert F. Storey, Pierre Théroux, et al.. (2015). Abstract 19642: Consistent Benefit of Ticagrelor Both Early and Late in Patients With Prior MI in PEGASUS-TIMI 54. Circulation. 132(suppl_3). 1 indexed citations
3.
Mentz, Robert J., Gad Cotter, John G.F. Cleland, et al.. (2014). International Differences in Clinical Characteristics, Management, and Outcomes in Acute Heart Failure Patients: Better Short-Term Outcomes in Patients Enrolled in Eastern Europe and Russia in the PROTECT Trial. European Journal of Heart Failure. 16(6). 614–624. 56 indexed citations
4.
Mega, Jessica L., Eugene Braunwald, Stephen D. Wiviott, et al.. (2013). Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2–TIMI 51). The American Journal of Cardiology. 112(4). 472–478. 35 indexed citations
5.
Scirica, Benjamin M., David A. Morrow, Christoph Bode, et al.. (2010). Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. European Heart Journal. 31(16). 1993–2005. 38 indexed citations
6.
Alexander, John H., Richard C. Becker, Deepak L. Bhatt, et al.. (2009). Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome. Circulation. 119(22). 2877–2885. 334 indexed citations
7.
Díaz, Rafael, Abhinav Goyal, Shamir R. Mehta, et al.. (2007). Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction. JAMA. 298(20). 2399–2399. 121 indexed citations
8.
9.
10.
Antman, Elliott M., David A. Morrow, Carolyn H. McCabe, et al.. (2006). Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction. New England Journal of Medicine. 354(14). 1477–1488. 349 indexed citations
11.
Prabhakaran, Dorairaj, Salim Yusuf, Shamir R. Mehta, et al.. (2005). Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.. PubMed. 57(3). 217–25. 63 indexed citations
12.
Tebbe, Ulrich, Rolf Michels, Jennifer Adgey, et al.. (1998). Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial fn1fn1This study was supported by Grünenthal GmbH, the manufacturer of saruplase.. Journal of the American College of Cardiology. 31(3). 487–493. 68 indexed citations
13.
Tebbe, Ulrich, Rolf Michels, Jennifer Adgey, et al.. (1996). Thrombolysis with saruplase is at least as effective in AMI as streptokinase: COMPASS double-blind study in 3089 patients. Journal of the American College of Cardiology. 27(2). 166–166. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.M. Pelletier Breakdown of academic impact, for papers by Henrik Renlund Breakdown of academic impact, for papers by Petr Widimský Breakdown of academic impact, for papers by HD White Breakdown of academic impact, for papers by Axel de Labriolle Breakdown of academic impact, for papers by Kelly Maresh Breakdown of academic impact, for papers by Khagendra Dahal Breakdown of academic impact, for papers by Jindřich Špinar Breakdown of academic impact, for papers by Conor F. Lundergan Breakdown of academic impact, for papers by Alec Vahanian
Rankless by CCL
2026